for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Seegene Inc

096530.KQ

Latest Trade

51,900.00KRW

Change

0.00(0.00%)

Volume

613,515

Today's Range

50,600.00

 - 

52,500.00

52 Week Range

48,200.00

 - 

147,200.00

As of on the KOSDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
51,900.00
Open
52,300.00
Volume
613,515
3M AVG Volume
16.45
Today's High
52,500.00
Today's Low
50,600.00
52 Week High
147,200.00
52 Week Low
48,200.00
Shares Out (MIL)
51.80
Market Cap (MIL)
2,710,529.00
Forward P/E
5.50
Dividend (Yield %)
1.49

Next Event

Q3 2021 Seegene Inc Earnings Release

Latest Developments

More

Seegene Announces Submission To U.S. FDA For Emergency Use Authorization Of Its Allplextm Sars-Cov-2/Flua/Flub/Rsv Assay

Cirrusdx Laboratory Receives Emergency Use Authorization From FDA For Covid-19 Testing

Eurobio Scientific Launches ALLPLEX CORONAVIRUS With Seegene

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Seegene Inc

Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The Company provides its products under the brand names of Seeplex, Anyplex and Magicplex. The Company distributes its products within domestic market and to overseas markets.

Industry

Biotechnology & Drugs

Contact Info

Taewon Bldg., 91, Ogeum-ro, Songpa-gu

05548

South Korea

+82.2.22404000

http://www.seegene.com/

Executive Leadership

Jin Su Choi

President, Director

Jong Yun Cheon

Chief Executive Officer, Director

Beom Jun Kim

Vice President

Gi Seon Lee

Vice President

Jun Yeong Lee

Vice President

Key Stats

1.25 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, KRW)

2018

0.1K

2019

0.1K

2020

1.1K

2021(E)

1.3K
EPS (KRW)

2018

189.000

2019

513.000

2020

9,662.000

2021(E)

9,431.667
Price To Earnings (TTM)
4.36
Price To Sales (TTM)
1.90
Price To Book (MRQ)
3.09
Price To Cash Flow (TTM)
4.22
Total Debt To Equity (MRQ)
12.92
LT Debt To Equity (MRQ)
7.23
Return on Investment (TTM)
96.36
Return on Equity (TTM)
71.65

Latest News

Latest News

S.Korea's Seegene develops first COVID-19 test kit that can detect multiple variants

South Korea's Seegene Inc said on Monday it developed the world's first COVID-19 diagnostic test that is capable of identifying multiple mutant variants of the virus in a single reaction.

BRIEF-Seegene Exports 10 Million Corona Tests To Brazil

* SEEGENE INC - WILL EXPORT 10 MILLION TESTS OF ITS COVID-19 TESTING KITS TO PAN AMERICAN HEALTH ORGANIZATION / WHO THROUGH BRAZILIAN UNIT Source text for Eikon: Further company coverage:

BRIEF-Eurobio Scientific: CE Marking Of Seegene Coronavirus Test

* CE MARKING OF SEEGENE CORONAVIRUS TEST Source text for Eikon: Further company coverage: (Gdansk Newsroom)

BRIEF-Eurobio Scientific Launches ALLPLEX CORONAVIRUS With Seegene

* A FIRST TEST FROM THE PARTNER SEEGENE IS ALREADY MARKETED FOR RESEARCH LABORATORIES

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up